Therapeutic Expertise Spherix Global Insights possesses deep knowledge across seven key therapeutic areas including Dermatology, Gastroenterology, Nephrology, CNS, Rheumatology, Ophthalmology, and Hematology/Oncology, positioning it as a strategic partner for companies seeking targeted market intelligence and tailored research tools within the life sciences sector.

Innovative Market Tools The company’s launch of specialized products like Market Dynamix and Patient Chart Dynamix demonstrates a focus on delivering real-time, actionable insights on drug launches, biosimilars, and treatment patterns—creating opportunities to support clients with competitive positioning and market entry strategies.

Expanding Oncology Focus Recent product launches such as the PD-1 Inhibition in Solid Tumors and ongoing tracking of Vabysmo suggest a strategic expansion into oncology and ophthalmology markets, offering sales teams opportunities to engage with pharmaceutical companies developing advanced biologics and targeted therapies.

Partnership Opportunities Collaborations with organizations like the American Kidney Fund and focus on nephrology indicate a growing emphasis on chronic disease management and patient engagement, providing additional avenues to introduce companion diagnostics, patient support programs, and disease-specific insights.

Growth and Reach With revenue estimates between $25 million and $50 million and a client base spanning global markets, Spherix's expanding product offerings and niche expertise represent a valuable prospect for enterprise-level clients looking to deepen their market analysis and competitive intelligence capabilities in the life sciences industry.